|
1
|
Spyratos D and Sichletidis L: Umeclidinium
bromide/vilanterol combination in the treatment of chronic
obstructive pulmonary disease: A review. Ther Clin Risk Manag.
11:481–487. 2015.PubMed/NCBI
|
|
2
|
Zhong J and Roth M: Clinical potential of
aclidinium bromide in chronic obstructive pulmonary disease. Ther
Clin Risk Manag. 10:449–453. 2014.PubMed/NCBI
|
|
3
|
Vitacca M, Bianchi L, Bazza A and Clini
EM: Advanced COPD patients under home mechanical ventilation and/or
long term oxygen therapy: Italian healthcare costs. Monaldi Arch
Chest Dis. 75:207–214. 2011.PubMed/NCBI
|
|
4
|
Faenza S and Petrini F: Mechanical
ventilation in the emergency room. Minerva Anestesiol. 66:883–887.
2000.(In Italian). PubMed/NCBI
|
|
5
|
Brijker F, van den Elshout FJ, de Rijk A,
Folgering HT and Bosch FH: Use of noninvasive mechanical
ventilation to avoid intubation during acute respiratory
insufficiency. Ned Tijdschr Geneeskd. 143:1819–1823. 1999.(In
Dutch). PubMed/NCBI
|
|
6
|
Hashemian SM, Mortaz E, Jamaati H, Bagheri
L, Mohajerani SA, Garssen J, Movassaghi M, Barnes PJ, Hill NS and
Adcock IM: Budesonide facilitates weaning from mechanical
ventilation in difficult-to-wean very severe COPD patients:
Association with inflammatory mediators and cells. J Crit Care.
44:161–167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dixit D, Bridgeman MB, Andrews LB,
Narayanan N, Radbel J, Parikh A and Sunderram J: Acute
exacerbations of chronic obstructive pulmonary disease: Diagnosis,
management, and prevention in critically ill patients.
Pharmacotherapy. 35:631–648. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu YH, Ma SD, Fu QJ, Zhao LY, Li Y, Wang
HQ and Li MC: Effect of lentinan on membrane-bound protein
expression in splenic lymphocytes under chronic low-dose radiation.
Int Immunopharmacol. 22:505–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maltais F, Ostinelli J, Bourbeau J, Tonnel
AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB and
Duroux P: Comparison of nebulized budesonide and oral prednisolone
with placebo in the treatment of acute exacerbations of chronic
obstructive pulmonary disease: A randomized controlled trial. Am J
Respir Crit Care Med. 165:698–703. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma Z and Zhang W: Short-term versus longer
duration of glucocorticoid therapy for exacerbations of chronic
obstructive pulmonary disease. Pulm Pharmacol Ther. 40:84–90. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vogelmeier CF, Criner GJ, Martínez FJ,
Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M,
Fabbri LM, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive lung disease 2017 report:
GOLD executive summary. Arch Bronconeumol. 53:128–149. 2017.(In
English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rudan I, Campbell H, Marušić A, Sridhar D,
Nair H, Adeloye D, Theodoratou E and Chan KY: Assembling GHERG:
Could ‘academic crowd-sourcing’ address gaps in global health
estimates? J Glob Health. 5:0101012015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uren NG, Davies SW, Jordan SL and Lipkin
DP: Inhaled bronchodilators increase maximum oxygen consumption in
chronic left ventricular failure. Eur Heart J. 14:744–750. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yalçınsoy M, Salturk C, Takır HB, Kutlu
SB, Oguz A, Aksoy E, Balcı M, Kargın F, Mocin OY, Adıguzel N, et
al: Case fatality rate related to nosocomial and
ventilator-associated pneumonia in an ICU: A single-centre
retrospective cohort study. Wien Klin Wochenschr. 128:95–101. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boixeda R, Bacca S, Elias L, Capdevila JA,
Vilà X, Mauri M and Almirall J: Pneumonia as comorbidity in chronic
obstructive pulmonary disease (COPD). Differences between acute
exacerbation of COPD and pneumonia in patients with COPD. Arch
Bronconeumol. 50:514–520. 2014.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McCurdy BR: Noninvasive positive pressure
ventilation for acute respiratory failure patients with chronic
obstructive pulmonary disease (COPD): An evidence-based analysis.
Ont Health Technol Assess Ser. 12:1–102. 2012.
|
|
17
|
Xiong G, Xu L, Wei L and Li X: Atomization
inhalation of terbutaline and budesonide efficiently improved
immunity and lung function of AECOPD patients. Cell Mol Immunol.
5:287–291. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leivo-Korpela S, Lehtimäki L, Vuolteenaho
K, Nieminen R, Kööbi L, Järvenpää R, Kankaanranta H, Saarelainen S
and Moilanen E: Adiponectin is associated with dynamic
hyperinflation and a favourable response to inhaled glucocorticoids
in patients with COPD. Respir Med. 108:122–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kirdar S, Serter M, Ceylan E, Sener AG,
Kavak T and Karadağ F: Adiponectin as a biomarker of systemic
inflammatory response in smoker patients with stable and
exacerbation phases of chronic obstructive pulmonary disease. Scand
J Clin Lab Invest. 69:219–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Zhang J, Zhang Q, Yang X, Shan H,
Ming Z, Chen H, Liu Y, Yin J and Li Y: D-dimer as a potential
biomarker for the progression of COPD. Clin Chim Acta. 455:55–59.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beringer A, Noack M and Miossec P: IL-17
in Chronic Inflammation: From Discovery to Targeting. Trends Mol
Med. 22:230–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai BQ, Cai SX, Chen RC, et al: Expert
consensus on acute exacerbation of chronic obstructive pulmonary
disease in the People's Republic of China. Int J Chron Obstruct
Pulmon Dis. 9:381–95. 2014.PubMed/NCBI
|
